The benefits of partial agonists in the treatment of schizophrenia
In this video, Prof Andrea Fagiolini discusses why partial agonists are suitable for the treatment of schizophrenia and if they can be used in the acute setting.
-
Body
PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia. This product is not listed on the PBS for the treatment of agitation associated with Alzheimer’s dementia.
-
Body
Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:REXULTI® is a registered trademark of H. Lundbeck A/S. REXULTI® is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
-
Body
Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
This product is not listed on the PBS for the treatment of bipolar 1 disorder. -
Body
Please review Approved Product Information before prescribing. Product Information is available by calling Lundbeck on 1300 721 277 or by clicking: Abilify Maintena PI
Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Abilify Maintena is co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.
Related
Contributor
Prof Andrea Fagiolini